| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Zhejiang AngLiKang Pharmaceutical CO.LTD (SHE: 002940)
002940 Technical Analysis
4
| As on 1st Apr 2026 002940 STOCK Price closed @ 34.88 and we RECOMMEND Buy for LONG-TERM with Stoploss of 27.42 & Strong Buy for SHORT-TERM with Stoploss of 13.72 we also expect STOCK to react on Following IMPORTANT LEVELS. |
002940STOCK Price
| Open | 31.72 | Change | Price | % |
| High | 34.88 | 1 Day | 3.17 | 10.00 |
| Low | 31.72 | 1 Week | 7.50 | 27.39 |
| Close | 34.88 | 1 Month | 2.11 | 6.44 |
| Volume | 21691006 | 1 Year | 20.66 | 145.29 |
| 52 Week High 64.70 | 52 Week Low 12.40 | ||||
SHE China Most Active Stocks
| 002309 | 4.53 | -8.30% |
| 000008 | 3.27 | 0.00% |
| 002506 | 4.82 | 1.47% |
| 000725 | 4.01 | 2.56% |
| 002310 | 3.19 | -6.73% |
| 000592 | 12.02 | -5.95% |
| 002263 | 4.30 | -4.66% |
| 002131 | 7.73 | -1.02% |
| 002323 | 2.45 | 3.81% |
| 000767 | 3.90 | -7.80% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
| 002940 Daily Charts |
002940 Intraday Charts |
Whats New @ Bazaartrend |
002940 Free Analysis |
|
|
002940 Important Levels Intraday
| RESISTANCE | 40.97 |
| RESISTANCE | 39.02 |
| RESISTANCE | 37.81 |
| RESISTANCE | 36.60 |
| SUPPORT | 33.16 |
| SUPPORT | 31.95 |
| SUPPORT | 30.74 |
| SUPPORT | 28.79 |
002940 Forecast April 2026
| 4th UP Forecast | 39.68 |
| 3rd UP Forecast | 38.14 |
| 2nd UP Forecast | 37.19 |
| 1st UP Forecast | 36.24 |
| 1st DOWN Forecast | 33.52 |
| 2nd DOWN Forecast | 32.57 |
| 3rd DOWN Forecast | 31.62 |
| 4th DOWN Forecast | 30.08 |
002940 Weekly Forecast
| 4th UP Forecast | 37.19 |
| 3rd UP Forecast | 36.45 |
| 2nd UP Forecast | 35.99 |
| 1st UP Forecast | 35.53 |
| 1st DOWN Forecast | 34.23 |
| 2nd DOWN Forecast | 33.77 |
| 3rd DOWN Forecast | 33.31 |
| 4th DOWN Forecast | 32.57 |
002940 Forecast2026
| 4th UP Forecast | 145.41 |
| 3rd UP Forecast | 109.96 |
| 2nd UP Forecast | 88.05 |
| 1st UP Forecast | 66.14 |
| 1st DOWN Forecast | 3.62 |
| 2nd DOWN Forecast | -18.29 |
| 3rd DOWN Forecast | -40.2 |
| 4th DOWN Forecast | -75.65 |
Zhejiang AngLiKang Pharmaceutical CO.LTD ( SHE China Symbol : 002940 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
002940 Business Profile
Zhejiang Anglikang Pharmaceutical Co., Ltd. produces and sells bulk pharmaceutical materials, pharmaceutic preparations, and medical empty capsules. The company offers pharmaceutical preparations, such as Levamlodipine Besylate, Levofloxacin Hydrochloride, Nifedipine sustain-released, Cefaclor sustained-release, Cefpodoxime Proxetil tablets, as well as Cefaclor capsules and granules. It also provides APLs, including Cefradine, Cefalexin, Cefradine sterile with L-arginine, Cefadroxil, Cefaclor, Cefixime, Doxofylline, Oryzanol, Telmisartan, and 7-Amino-3-methyl-3-cephem-4-carboxylic acid, as well as Ketoleucine, Ketovaine, D, L-Ketoisoleucine, D, L-a-Hydroxymethionine, and Ketone phenylalanine calcium. The company was founded in 2001 and is based in Shengzhou, China. Address: 1000, Shengzhou North Road, Shengzhou, China, 312400
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service